Literature DB >> 17397173

Syntheses of amamistatin fragments and determination of their HDAC and antitumor activity.

Kelley A Fennell1, Marvin J Miller.   

Abstract

[reaction: see text] Amamistatins A and B are natural products found to have anti-proliferative effects against MCF-7, A549, and MKN45 human tumor cell lines (IC50 0.24-0.56 microM). It was proposed that their activity was due to histone deacetylase (HDAC) inhibition mediated by the N-formyl-N-hydroxy lysine moiety. Amamistatin B fragment analogs were synthesized and screened for biological activity. These compounds were modest HDAC inhibitors and showed antitumor activity against MCF-7 and PC-3 human tumor cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397173     DOI: 10.1021/ol070382e

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  7 in total

1.  Epigenetic changes induced by curcumin and other natural compounds.

Authors:  Simone Reuter; Subash C Gupta; Byoungduck Park; Ajay Goel; Bharat B Aggarwal
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

2.  N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines.

Authors:  Jonathan A Stefely; Rahul Palchaudhuri; Patricia A Miller; Rebecca J Peterson; Garrett C Moraski; Paul J Hergenrother; Marvin J Miller
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

3.  Syntheses and studies of amamistatin B analogs reveals that anticancer activity is relatively independent of stereochemistry, ester or amide linkage and select replacement of one of the metal chelating groups.

Authors:  Chunrui Wu; Patricia A Miller; Marvin J Miller
Journal:  Bioorg Med Chem Lett       Date:  2011-01-22       Impact factor: 2.823

4.  Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives.

Authors:  Dong Lu; Juan Yan; Lang Wang; Hongchun Liu; Limin Zeng; Minmin Zhang; Wenwen Duan; Yinchun Ji; Jingchen Cao; Meiyu Geng; Aijun Shen; Youhong Hu
Journal:  ACS Med Chem Lett       Date:  2017-07-18       Impact factor: 4.345

5.  Histone deacetylase modulators provided by Mother Nature.

Authors:  Carole Seidel; Michael Schnekenburger; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2012-02-12       Impact factor: 5.523

Review 6.  Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents.

Authors:  Madhusoodanan Mottamal; Shilong Zheng; Tien L Huang; Guangdi Wang
Journal:  Molecules       Date:  2015-03-02       Impact factor: 4.411

Review 7.  The diversity and utility of arylthiazoline and aryloxazoline siderophores: challenges of total synthesis.

Authors:  Karolina Kamińska; Andrzej Mular; Evgenia Olshvang; Nils Metzler Nolte; Henryk Kozłowski; Elżbieta Wojaczyńska; Elżbieta Gumienna-Kontecka
Journal:  RSC Adv       Date:  2022-09-07       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.